Real-world characteristics of patients with sickle cell disease who initiated crizanlizumab therapy.

The Unique Magnetic Signature of Sickle Red Blood Cells: A Comparison Between the Red Blood Cells of Transfused and Non-Transfused Sickle Cell Disease Patients and Healthy Donors.

The Evolving Landscape of Drug Therapies for Sickle Cell Disease.

Elevated tricuspid regurgitation velocity is associated with increased adverse haematologic events during pregnancy in women with sickle cell disease.

GRNDaD: big data and sickle cell disease.

Potential of cell tracking velocimetry as an economical and portable hematology analyzer.

Treatment dilemmas: strategies for priapism, chronic leg ulcer disease, and pulmonary hypertension in sickle cell disease.

Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.

Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.

Red blood cells differentiated in vitro using sequential liquid and semi-solid culture as a pre-clinical model.